Precision Business Insights
Portfolio

 

Amyotrophic Lateral Sclerosis Pipeline Drugs Key Targets

ImageReport NamePrice
Amyotrophic Lateral Sclerosis Pipeline Drugs Assessment: Clinical Trails Analysis, Player Profiles, Collaborations, Key Targets, Geographic Focus, and Data Publications, 2018$ 2,000.00$ 6,000.0036200000